Hypermethylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma

Ho, 1978, An epidemiologic and clinical study of nasopharyngeal carcinoma, Int J Radiat Oncol Biol Phys, 4, 182, 10.1016/0360-3016(78)90137-2 Feinmesser, 1992, Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissues obtained by fine-needle aspiration, N Engl J Med, 326, 17, 10.1056/NEJM199201023260103 Gulley, 1998, Epstein-Barr virus infection is associated with p53 accumulation in nasopharyngeal carcinoma, Hum Pathol, 29, 252, 10.1016/S0046-8177(98)90044-2 Niemhom, 2000, Co-expression of p53 and bcl-2 may correlate to the presence of Epstein-Barr virus genomes and the expression of proliferating cell nuclear antigen in nasopharyngeal carcinoma, Cancer Lett, 160, 199, 10.1016/S0304-3835(00)00582-6 Choi, 1997, Nasopharyngeal carcinoma: genetic changes, Epstein-Barr virus infection, or both clinical and molecular study of 36 patients, Cancer, 72, 2873, 10.1002/1097-0142(19931115)72:10<2873::AID-CNCR2820721003>3.0.CO;2-A Yao, 1982, Epidemiological characteristics and presumed carcinogenesis of nasopharyngeal carcinoma in Hunan province-based on 1973–1975 cancer mortality survey, Bull Hunan Med Coll, 7, 10 Merlo, 1995, 5′ CpG island methylation is associated with transcriptional silencing of the tumors suppressor p16/CDKN2/MTS1 in human cancers, Nat Med, 1, 686, 10.1038/nm0795-686 Kwong, 2000, Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma, Clin Cancer Res, 8, 131 Chang, 2003, Detection of hypermethylated R1Z1 gene in primary tumor, mouth and throat rinsing fluid, nasopharyngeal swab and peripheral blood of nasopharyngeal carcinoma patients, Clin Cancer Res, 9, 1033 Wong, 2004, Quantitation plasma hypermethylated DNA markers of undifferentiated nasopharyngeal carcinoma, Clin Cancer Res, 10, 2401, 10.1158/1078-0432.CCR-03-0139 Kong, 2006, Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma, Anticancer Drugs, 17, 251, 10.1097/00001813-200603000-00003 Zhou, 2005, Frequent hypermethylation RASSF1A and TSLC1, and high viral load of Epstein-Barr virus DNA in nasopharyngeal carcinoma and match tumor-adjacent tissues, Neoplasia, 7, 809, 10.1593/neo.05217 Tsai, 2002, The Epstein-Barr virus oncogene product, latent membrane protein 1, induce the down-regulation of E-cadherin gene expression via activation of DNA methyltransferase, Proc Natl Acad Sci USA, 99, 10084, 10.1073/pnas.152059399 Tsai, 2006, Activation of DNA methyltransferase 1 by EBV LMP1 involves C-Jun NH2-terminal kinase signaling, Cancer Res, 66, 11668, 10.1158/0008-5472.CAN-06-2194 Vleminckx, 1991, Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role, Cell, 66, 107, 10.1016/0092-8674(91)90143-M Navarro, 1991, A role for the E-cadherin cell–cell adhesion molecule during tumor progression of mouse epidermal carcinogenesis, J Cell Biol, 115, 517, 10.1083/jcb.115.2.517 Oka, 1993, Expression of E-cadherin cell adhesion molecules in human breast cancers tissues and its relationship to metastasis, Cancer Res, 53, 1696 Umbas, 1992, Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer, Cancer Res, 52, 5104 Dorudi, 1993, E-cadherin expression in colorectal cancer, Am J Pathol, 142, 981 Katagiri, 1994, E-cadherin expression in renal cell cancer and its significance in metastasis and survival, Br J Cancer, 71, 376, 10.1038/bjc.1995.76 Pignatelli, 1994, Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage, J Pathol, 174, 243, 10.1002/path.1711740403 Brabant, 1993, E-cadherin: a differentiation marker in thyroid malignancy, Cancer Res, 53, 4987 Schipper, 1991, E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis, Cancer Res, 51, 6328 Zheng, 1999, Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis, Hum Pathol, 30, 458, 10.1016/S0046-8177(99)90123-5 Krishna, 2005, Down regulation of adhesion protein E-cadherin in Epstein-Barr virus infected nasopharyngeal carcinomas, Cancer Biomark, 1, 271, 10.3233/CBM-2005-1602 Greer, 1991, PCR amplification from paraffin-embedded tissues: effects of fixative and fixation time, Am J Clin Pathol, 95, 117, 10.1093/ajcp/95.2.117 Herman, 1996, Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands, Proc Natl Acad Sci USA, 93, 9821, 10.1073/pnas.93.18.9821 Frommer, 1992, A genomic sequencing protocol that yields a positive display of 5-methylcytosine residuals in individual DNA strands, Proc Natl Acad Sci USA, 89, 1827, 10.1073/pnas.89.5.1827 Olek, 1996, A modified and improved method for bisulfite based cytosine methylation analysis, Nucleic Acid Res, 24, 5064, 10.1093/nar/24.24.5064 Kitazawa, 2000, Identification of methylated cytosine from archival formalin-fixed paraffin-embedded specimens, Lab Invest, 80, 275, 10.1038/labinvest.3780031 Lee Anne, 1999, Staging of nasopharyngeal carcinoma: from Ho's to the new UICC system, Int J Cancer, 84, 179, 10.1002/(SICI)1097-0215(19990420)84:2<179::AID-IJC15>3.0.CO;2-6 Birchmeier, 1994, Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness, Biochem Biophys Acta, 1198, 11 Yoshiura, 1995, Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas, Proc Natl Acad Sci USA, 92, 7416, 10.1073/pnas.92.16.7416 Li, 2004, Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma, Chin Med J, 117, 1232 Bringuir, 1993, Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors, Cancer Res, 55, 3241 Mattussen, 1993, E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome, Int J Cancer, 55, 580, 10.1002/ijc.2910550411 Lo, 2002, Genetic and epigenetic changes in nasopharyngeal carcinoma, Semin Cancer Biol, 12, 451, 10.1016/S1044579X02000883 Chuang, 2007, Hypermethylation of the CpG islands in the promoter region flanking GSTP1 gene is a potential plasma DNA biomarker for detecting prostate carcinoma, Cancer Detect Prev, 31, 59, 10.1016/j.cdp.2006.11.001 Yang, 2006, DNA methylation changes after 5-Aza-2′-deoxycytidine therapy in patients with leukemia, Cancer Res, 66, 5495, 10.1158/0008-5472.CAN-05-2385